Valisure proudly partnered with Senator Richard Blumenthal to spotlight the urgent public health risks posed by the presence of benzene, a known human carcinogen, in popular acne treatment products.
At a joint press conference held in Hartford, Connecticut, Valisure’s Co-Founder & President David Light joined Senator Blumenthal to present the findings of Valisure’s latest research, which revealed that benzoyl peroxide-based acne products can degrade into benzene at high levels—posing a significant risk, particularly to young consumers.
The event, covered by NBC Connecticut, emphasized the need for immediate regulatory action. Senator Blumenthal announced his formal letter to the FDA, calling for urgent recalls and stronger oversight—an effort also reported by Bloomberg.
“This is a wake-up call. Benzene has no place in consumer products, especially those marketed to teenagers,” said Senator Blumenthal.
Valisure remains committed to working alongside lawmakers and regulators to improve transparency, enforce accountability, and ensure that everyday health products meet the highest safety standards.
Watch NBC CT Coverage →
Read Bloomberg’s Report on the FDA Letter →
Valisure proudly partnered with Senator Richard Blumenthal to spotlight the urgent public health risks posed by the presence of benzene, a known human carcinogen, in popular acne treatment products.
At a joint press conference held in Hartford, Connecticut, Valisure’s Co-Founder & President David Light joined Senator Blumenthal to present the findings of Valisure’s latest research, which revealed that benzoyl peroxide-based acne products can degrade into benzene at high levels—posing a significant risk, particularly to young consumers.
The event, covered by NBC Connecticut, emphasized the need for immediate regulatory action. Senator Blumenthal announced his formal letter to the FDA, calling for urgent recalls and stronger oversight—an effort also reported by Bloomberg.
“This is a wake-up call. Benzene has no place in consumer products, especially those marketed to teenagers,” said Senator Blumenthal.
Valisure remains committed to working alongside lawmakers and regulators to improve transparency, enforce accountability, and ensure that everyday health products meet the highest safety standards.
Watch NBC CT Coverage →
Read Bloomberg’s Report on the FDA Letter →
Valisure proudly partnered with Senator Richard Blumenthal to spotlight the urgent public health risks posed by the presence of benzene, a known human carcinogen, in popular acne treatment products.
At a joint press conference held in Hartford, Connecticut, Valisure’s Co-Founder & President David Light joined Senator Blumenthal to present the findings of Valisure’s latest research, which revealed that benzoyl peroxide-based acne products can degrade into benzene at high levels—posing a significant risk, particularly to young consumers.
The event, covered by NBC Connecticut, emphasized the need for immediate regulatory action. Senator Blumenthal announced his formal letter to the FDA, calling for urgent recalls and stronger oversight—an effort also reported by Bloomberg.
“This is a wake-up call. Benzene has no place in consumer products, especially those marketed to teenagers,” said Senator Blumenthal.
Valisure remains committed to working alongside lawmakers and regulators to improve transparency, enforce accountability, and ensure that everyday health products meet the highest safety standards.
Watch NBC CT Coverage →
Read Bloomberg’s Report on the FDA Letter →
Valisure proudly partnered with Senator Richard Blumenthal to spotlight the urgent public health risks posed by the presence of benzene, a known human carcinogen, in popular acne treatment products.
At a joint press conference held in Hartford, Connecticut, Valisure’s Co-Founder & President David Light joined Senator Blumenthal to present the findings of Valisure’s latest research, which revealed that benzoyl peroxide-based acne products can degrade into benzene at high levels—posing a significant risk, particularly to young consumers.
The event, covered by NBC Connecticut, emphasized the need for immediate regulatory action. Senator Blumenthal announced his formal letter to the FDA, calling for urgent recalls and stronger oversight—an effort also reported by Bloomberg.
“This is a wake-up call. Benzene has no place in consumer products, especially those marketed to teenagers,” said Senator Blumenthal.
Valisure remains committed to working alongside lawmakers and regulators to improve transparency, enforce accountability, and ensure that everyday health products meet the highest safety standards.
Watch NBC CT Coverage →
Read Bloomberg’s Report on the FDA Letter →